Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • Français
  • my CNW 
    • Login
    • Register
  • Client Login
  • Sign Up
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    Advanced Search
    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Canadian Federal Government
        • Canadian Municipal Government
        • Canadian Provincial Government
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Advanced Search
    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • IR
    • All Products
    • Become a Client
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • General Enquiries
    • Media
    • Worldwide Offices
    • Hamburger menu
    • Cision Canada
    • Send a Release
    • FR
      • Phone

      • 877-269-7890 from 8 AM - 10 PM ET

      • ALL CONTACT INFO
      • Contact Cision

        877-269-7890
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Sign Up
      • Resources
      • Investor Relations
      • Journalists
      • Webcasts
      • my CNW
      • GDPR
      • 3 News in Focus
      • 5 Business
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Sign Up
      • Resources
      • Investor Relations
      • Journalists
      • Webcasts
      • my CNW
      • GDPR
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • IR
      • All Products
      • Send a Release
      • Sign Up
      • Resources
      • Investor Relations
      • Journalists
      • Webcasts
      • my CNW
      • GDPR
      • Become a Client
      • Request a Demo
      • Editorial Bureaus
      • Partnerships
      • General Enquiries
      • Media
      • Worldwide Offices
      • General Enquiries
      • Send a Release
      • Sign Up
      • Resources
      • Investor Relations
      • Journalists
      • Webcasts
      • my CNW
      • GDPR
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business) Business
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Ontario not prepared to fully benefit from coming treatment for Alzheimer's disease, new research reveals


      News provided by

      Alzheimer Society of Ontario

      Sep 22, 2022, 10:59 ET

      Share this article

      Share this article


      Preparing for a future disease-modifying therapy for Alzheimer's disease will help reduce wait times, avoid disease progression.

      TORONTO, Sept. 22, 2022 /CNW/ - Research out of the University of Southern California released yesterday, World Alzheimer's Day, found that Ontario could save up to $9.9 billion in long-term care costs over 20 years with a disease-modifying treatment for Alzheimer's disease—but that today, Ontario is poorly positioned to take advantage of any Health Canada-approved treatment.

      "Our findings give cause for both hope and for concern," said Dr. Soeren Mattke, an expert in innovative chronic illness care and lead researcher of the study.  "Hope, because a therapy for Alzheimer's disease has the potential to fundamentally alter how Ontario cares for older adults living with dementia.  Yet concern, because the province clearly is behind its international peers in preparing for this breakthrough."

      There is no prevention, cure, or disease-slowing treatment for Alzheimer's disease, the most common type of dementia in Ontario and around the world, that has been authorised for use in Canada.  Currently, there are four medications approved by Health Canada: three are publicly funded in Ontario, however each of these target symptoms of Alzheimer's disease at the dementia stage and do not treat the earliest symptoms nor slow progression of the disease itself.  While non-pharmacological approaches to dementia, such as exercise, cognitive engagement, and social interaction, may confer benefits to the brain, these do not replace the need for disease-modifying medications for Alzheimer's disease.

      In June, 2021 the United States became the first jurisdiction in the world to approve a disease-modifying pharmacological treatment for Alzheimer's disease.  Several disease-modifying medications are at varying stages of review in Canada, and Ontario is potentially years—not decades—away from its first ever disease-modifying therapy for Alzheimer's disease.

      "The over 260,000 Ontarians living with dementia today, and their families, are closely following news of a possible treatment," said Cathy Barrick, CEO of the Alzheimer Society of Ontario.  "There is an expectation among families that the provincial and federal governments work together to prepare for the approval and rollout of a disease-modifying therapy.  People have hope, and if a treatment is approved and used elsewhere while Ontario struggles to catch up, that hope will quickly turn to despair, and anger."

      Research findings show that Ontario will spend $27.8 billion between 2023 and 2043 on alternate level of care (ALC) and long-term care (LTC) costs associated with people living with dementia.  With the theoretical approval of a disease-modifying therapy for Alzheimer's disease in 2023, these costs would decrease by $6.1 billion, a 22% reduction over 20 years.  If, however, Ontario removes all constraints on detecting and diagnosing cases of dementia, the province will save an additional $3.8 billion over the same time frame for total savings of $9.9 billion.

      "Treatments currently in late phase development, and for which approvals are anticipated, will need to be initiated when people are still at the early stages of Alzheimer's disease," explained Dr. Sharon Cohen, neurologist and Medical Director of Toronto Memory Program.  "Capacity to detect and diagnose Alzheimer's disease at its earliest stages is crucial in order to leverage the benefit of upcoming treatments.  However, today, most Ontarians living with Alzheimer's disease are diagnosed late—after several years of symptoms, imprecisely, or not at all.  The status quo for diagnosis of this disease is neither timely nor accurate and will require substantial revision to allow the affected population to benefit from breakthrough therapies."

      According to findings* earlier this year Canada is projected to have the longest wait times for a dementia diagnosis of any G7 country.  With the introduction of a disease-modifying therapy, wait times for a diagnosis will peak at over seven and a half years by 2029—longer than the expected lifespan of many Ontarians who come forward with concerns about dementia today.  This wait time would mean that the average Ontarian would not be able to access a treatment for Alzheimer's disease. The harsh reality:  by the time they receive a diagnosis, the disease will almost certainly have progressed to a point at which the treatment is no longer effective.

      "This research is an early warning," continued Ms. Barrick.  "A treatment is coming.  Ontario isn't ready."

      The full study is available at: https://alzheimer.ca/on/en/take-action/policy-advocacy/statements-releases-resources

      About the Alzheimer Society

      The Alzheimer Society is a federation of 26 frontline community support service providers, operating in every community across Ontario.  We supported over 95,000 clients last year, including both care partners and people living with dementia.  We provide education and training to physicians and other health care professionals, as well as to the general public, and work to reduce the stigma that is far too often associated with dementia.  As a health service provider, we offer system navigation, care partner respite, adult day programs, therapeutic recreation, and so much more at little or, for nearly all of our programs, no cost to families.  With hundreds of staff and thousands of volunteers we seek to alleviate the personal and social consequences of Alzheimer's disease and other types of dementia, and to promote research into a cure.

      * Mattke S, Wang M. Why would Canada have the longest wait times for an Alzheimer's treatment among the G7 countries? Canadian Health Policy. 2022 (JAN) doi: https://doi.org/10.54194/AKQT5456

      Alzheimer Society representatives and USC researchers are available for comment on the results of the study in English and French.

      Disclosure

      Study findings were subject to a double blind peer review and have been published in the Canadian Health Policy Journal.  The study was funded by a contract with the Alzheimer Society of Ontario, thanks to the generous support of an individual donor.  Alzheimer Society staff reviewed and provided feedback on a draft of the study, however neither the Society nor the donor had any influence on the study's methodology or findings.  The authors had full control over design, analysis, final manuscript, and decision to submit for publication.

      SOURCE Alzheimer Society of Ontario

      Media Contact: Beth Merrick, ZAZOU Communications, [email protected], (416) 473-9881

      Modal title

      Organization Profile

      Alzheimer Society of Ontario

        Also from this source

      • Alzheimer Society of Ontario report urges Canada to prioritize equitable access to Alzheimer's care as disease-modifying therapies enter the health system

      Contact PR Newswire

      • 866-245-2317
        from 7:30 AM - 6:30 PM ET
      • Become a Client
      • Request a Demo
      • Editorial Bureaus
      • Partnerships
      • General Enquiries
      • Media

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • Investor Relations

      About

      • About PR Newswire
      • About Cision
      • Careers
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • Platform Login
      • Privacy Policy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact Cision

      Products

      About

      My Services
      • All News Releases
      • Platform
      • Next Gen Communications Cloud
      • Cision Communications Cloud
      • my CNW
      877-269-7890
      from 8 AM - 10 PM ET
      • Terms of Use
      • Information Security Policy
      • Site Map
      • Cookie Settings
      • Accessibility Statement
      Copyright © 2026 CNW Group Ltd. All Rights Reserved. A Cision company.